Harrow Inc (HROW)
Harrow Market Cap: 571.77M for May 16, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 16, 2024 | 571.77M |
May 15, 2024 | 563.46M |
May 14, 2024 | 574.60M |
May 13, 2024 | 427.06M |
May 10, 2024 | 410.43M |
May 09, 2024 | 364.08M |
May 08, 2024 | 365.14M |
May 07, 2024 | 387.07M |
May 06, 2024 | 371.15M |
May 03, 2024 | 367.26M |
May 02, 2024 | 376.46M |
May 01, 2024 | 369.03M |
April 30, 2024 | 360.54M |
April 29, 2024 | 375.75M |
April 26, 2024 | 372.57M |
April 25, 2024 | 353.82M |
April 24, 2024 | 363.37M |
April 23, 2024 | 365.14M |
April 22, 2024 | 375.04M |
April 19, 2024 | 369.74M |
April 18, 2024 | 383.89M |
April 17, 2024 | 418.21M |
April 16, 2024 | 435.19M |
April 15, 2024 | 436.96M |
April 12, 2024 | 447.57M |
Date | Value |
---|---|
April 11, 2024 | 466.68M |
April 10, 2024 | 457.48M |
April 09, 2024 | 467.38M |
April 08, 2024 | 467.38M |
April 05, 2024 | 478.00M |
April 04, 2024 | 465.26M |
April 03, 2024 | 463.49M |
April 02, 2024 | 438.02M |
April 01, 2024 | 452.88M |
March 28, 2024 | 467.85M |
March 27, 2024 | 450.17M |
March 26, 2024 | 444.86M |
March 25, 2024 | 424.35M |
March 22, 2024 | 406.67M |
March 21, 2024 | 374.14M |
March 20, 2024 | 372.01M |
March 19, 2024 | 376.61M |
March 18, 2024 | 370.95M |
March 15, 2024 | 368.92M |
March 14, 2024 | 358.01M |
March 13, 2024 | 372.08M |
March 12, 2024 | 367.86M |
March 11, 2024 | 370.67M |
March 08, 2024 | 385.09M |
March 07, 2024 | 400.57M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Aquestive Therapeutics Inc | 298.61M |
Cyclacel Pharmaceuticals Inc | 3.085M |
Lifecore Biomedical Inc | 176.26M |
Relmada Therapeutics Inc | 105.31M |
Corvus Pharmaceuticals Inc | 136.99M |
Market Cap Related Metrics
PS Ratio | 3.950 |
PEG Ratio | -0.4229 |
Price to Book Value | 9.441 |
Price | 16.16 |
Earnings Yield | -5.69% |
PEGY Ratio | -0.4229 |